Trending...
- The Office of Count Jonathan of Aquitaine Establishes Centre for Education and Diplomacy
- Naperville Now Accepting Written Comments for City Board and Commission Meetings
- Iterators Named Preferred Accessibility Testing Vendor by MIT
SEATTLE, Aug. 21, 2025 ~ Orange Biomed, a leading developer in the healthcare industry, has recently gained international recognition for its revolutionary microfluidic technology. The company's innovative approach to chronic disease management has earned them a spot on Fortune Korea's "Top 40 Emerging South Korean Healthcare Innovations" list, solidifying their growing presence in the U.S. healthcare market.
At the core of Orange Biomed's success is their flagship product, the OBM rapid A1C. This pocket-sized device is the first of its kind to utilize microfluidic technology to measure glycated hemoglobin (A1C). Unlike traditional lab tests, this portable device offers a more accessible and accurate option for diabetes monitoring, particularly for patients who face barriers to regular testing.
The award panel responsible for selecting Orange Biomed for this prestigious recognition included U.S. medical experts and consulting firm BDMT Global. They were impressed by the company's ability to directly address unmet needs in the U.S. healthcare system. "The OBM rapid A1C could transform how diabetes patients monitor their condition by removing logistical and cost barriers associated with lab-based testing," stated evaluators.
More on illi News
In addition to their groundbreaking product development, Orange Biomed is also dedicated to making a positive impact beyond their technology. Through their "M.A.P. YOUR HEALTH" campaign, they have partnered with health and community groups in Chicago to raise awareness about chronic disease prevention and expand access to care.
CEO and co-president Yeaseul Park sees this recognition as validation of the company's commitment to global healthcare innovation. "Being named to the Top 40 is not only an honor but also proof that our technology can make a real impact in the U.S. healthcare system," Park stated. "Our focus is on building strong partnerships in the U.S. and turning these opportunities into tangible results in the healthcare system."
With over USD 7.5 million in funding and multiple innovation awards, Orange Biomed has presented their groundbreaking technology at major U.S. forums such as the American Diabetes Association's Innovation Hub and the Diabetes Technology Meeting (DTM). They have also engaged with professional communities through ADLM and ADCES. The company is currently preparing a 510(k) submission to the FDA for potential clearance of their product.
For more information on Orange Biomed and their innovative technology, please visit www.orangebiomed.com and follow them on LinkedIn, Instagram, Facebook, and Youtube. With their dedication to improving chronic disease management and accessibility in healthcare, Orange Biomed is sure to continue making waves in the industry.
At the core of Orange Biomed's success is their flagship product, the OBM rapid A1C. This pocket-sized device is the first of its kind to utilize microfluidic technology to measure glycated hemoglobin (A1C). Unlike traditional lab tests, this portable device offers a more accessible and accurate option for diabetes monitoring, particularly for patients who face barriers to regular testing.
The award panel responsible for selecting Orange Biomed for this prestigious recognition included U.S. medical experts and consulting firm BDMT Global. They were impressed by the company's ability to directly address unmet needs in the U.S. healthcare system. "The OBM rapid A1C could transform how diabetes patients monitor their condition by removing logistical and cost barriers associated with lab-based testing," stated evaluators.
More on illi News
- Connect With Purple Wave Auction At Farm Progress Show
- The Emotional Side of Foreclosure: How 4Closure Rescue LLC Helps Families Find Hope in Crisis
- Unlocking Amazon Savings: How Seller Promotional Codes Work — And How to Find Them Legitimately
- RUNWAY Milestones 1995-2025 Global Influence
- Google AI Mode Tells You Dr. Bob Akmens & BASports.com is the GOAT in College Football Handicapping
In addition to their groundbreaking product development, Orange Biomed is also dedicated to making a positive impact beyond their technology. Through their "M.A.P. YOUR HEALTH" campaign, they have partnered with health and community groups in Chicago to raise awareness about chronic disease prevention and expand access to care.
CEO and co-president Yeaseul Park sees this recognition as validation of the company's commitment to global healthcare innovation. "Being named to the Top 40 is not only an honor but also proof that our technology can make a real impact in the U.S. healthcare system," Park stated. "Our focus is on building strong partnerships in the U.S. and turning these opportunities into tangible results in the healthcare system."
With over USD 7.5 million in funding and multiple innovation awards, Orange Biomed has presented their groundbreaking technology at major U.S. forums such as the American Diabetes Association's Innovation Hub and the Diabetes Technology Meeting (DTM). They have also engaged with professional communities through ADLM and ADCES. The company is currently preparing a 510(k) submission to the FDA for potential clearance of their product.
For more information on Orange Biomed and their innovative technology, please visit www.orangebiomed.com and follow them on LinkedIn, Instagram, Facebook, and Youtube. With their dedication to improving chronic disease management and accessibility in healthcare, Orange Biomed is sure to continue making waves in the industry.
Filed Under: Business
0 Comments
Latest on illi News
- Chicago Public Schools and Mayor Brandon Johnson Extend Chicago Connected Program For 2025–26 School Year
- Advanced Renewable Concepts Launches "Solar – On The House™" Model to Expand Clean Energy in IL
- Delirious Comedy Club and House of Magic Open 2nd Location at Silver Sevens Hotel & Casino - Vegas-Quality Shows, Old Vegas Prices
- Koppers Announces Participation in Midwest IDEAS Investor Conference
- 8 Early Warning Signs —And How 4Closure Rescue LLC Helps Homeowners Act Before It's T
- Patrick A. Salvi II Named 2026 Best Lawyers 'Lawyer of the Year' for Chicago Area
- ENERICom Channel Releases Episode 2: "Floral!" of "The 1.5" Lifestyle Enjoyment Series
- South Shore Summer Fest Returns for Its 11th Year on Chicago's Lakefront
- Sumptuous Mobile Detailing Expands Premium Ceramic Coating & Mobile Car Detailing Across North Atlanta
- Save The Date: West Loop Contemporary Fine Art Expo Oct. 17-19
- The Data Detective's Epic Journey: How One Author Taught a Generation to Love Data
- OddsTrader Asks: What Are the Chances Your Team Makes the NFL Playoffs?
- Allison Longenbaugh Announces Resignation from Naperville City Council
- Iterators Named Preferred Accessibility Testing Vendor by MIT
- The 2025 "Aizu Festival" in Aizu Wakamatsu City will be held September 19–21
- Isringhausen BMW Unveils Newly Remodeled Showroom
- University Rankings Index Announces 2025 Rankings of the Top US Online Universities
- Boston Industrial Solutions Launches Citrine® CAL-685 Silicone Primer
- Heritage at South Brunswick Announces Two New Building Releases In Townhome Collection